FDA expands authorisation of two monoclonal antibodies for treatment and post-exposure prevention of COVID-19 to paediatric patients Read more
New analyses of two AZD7442 COVID-19 phase-III trials in high-risk populations confirm robust efficacy and long-term prevention Read more
ZD7442 reduces risk of developing severe COVID-19 or death in Tackle phase-III outpatient treatment trial Read more
NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms Read more
Government releases ‘National Clinical Management Protocol based on Ayurveda and Yoga for management of COVID-19’ Read more
Glenmark inks agreement with SaNOtize to commercialise nasal spray for COVID-19 treatment in India and other Asian markets Read more